Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A, Wang DJ, Shera D, Hurh P, Rupin J, Saslow E, Goldfarb O, Goldberg M, Larijani G, Sharrar W, Liouterman L, Camp A, Kolodny E, Samulski J, Leone P.
Janson C, et al. Among authors: hurh p.
Hum Gene Ther. 2002 Jul 20;13(11):1391-412. doi: 10.1089/104303402760128612.
Hum Gene Ther. 2002.
PMID: 12162821